Stay updated on Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial

Sign up to get notified when there's something new on the Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added to the record history, and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T10:17:59.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The record history now lists revision v3.3.2 and removes v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T16:54:03.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Removed the general government funding and operating status notice from the page, and the trial record content remains unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-17T15:03:48.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Study Status was updated in version 2 on 2021-10-25. Recruitment Status was updated in version 3 on 2023-07-26.
    Difference
    0.1%
    Check dated 2025-11-03T01:30:43.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    13%
    Check dated 2025-10-05T12:47:26.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T09:37:36.000Z thumbnail image

Stay in the know with updates to Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial page.